Posijet® News
![](/data/image/0/a/0aaeba0470383f841b873558c8776d11.1685530492.png)
Reducing skin doses and contamination exposure in PET with the Posijet®
31st May 2023
The Wales Research and Diagnostic PET Imaging Center is using the Lemer Pax autoinjector to administer FDG. Find out more here
![](/data/image/3/e/3e533649b3da8faad4a6418c4a5fe359.1673026946.jpg)
Automating the administration of high-energy radiopharmaceuticals for theranostics
5th January 2023
The Lemer Pax Posijet® autoinjector has been developed for vectorised internal radiotherapy using Lu-177 PSMA and Lu-177 DOTATATE. Learn more here
![](/data/image/6/a/6af74f3be5c81a2b1952d363a5470455.1649070846.png)
WATCH: Posijet® - automatic injector for radiopharmaceuticals
26th November 2021
The new generation Posijet® from Lemer Pax is an independent fractionation and injection unit for high energy radiopharmaceuticals. Click to read more.
![](/data/image/d/7/d71ec75c904451874f2e8432d2b67d19.1649065861.jpg)
Posijet has a positive impact at University Hospitals Coventry and Warwickshire NHS Trust
26th November 2021
The Nuclear Medicine Department of the University Hospitals Coventry and Warwickshire NHS Trust recently invested in a Lemer Pax Posijet.
![](/data/image/d/2/d2adfa9da910c8ef166240653f22d84c.1649069820.jpg)
Lemer Pax solutions for nuclear medicine
17th August 2021
From high energy radiopharmaceuticals units to tungsten syringe shields, view Lemer Pax's full range here.
![](/data/image/9/8/98f20791de6ed91882d94e3c9a79d687.1649069347.jpg)
Lemer Pax case study: Ensuring optimal conditions for radiation protection in a mobile medical imaging unit
6th October 2020
Read the latest case study from Lemer Pax about a mobile medical imaging unit in Switzerland containing the Posijet®.
![](/data/image/d/8/d889ca4718368071c86a02fa3aff2aad.1649070513.png)
How the Posijet® will increase PET-CT capability at Paul Strickland Scanner Center
4th April 2020
Paul Strickland Scanner Center choose a new Posijet® as part of a major upgrade, please click to read more.